rpmjResearch'n Practical Medicine JournalResearch and Practical Medicine Journal2410-1893"QUASAR", LLC10.17709/2409-2231-2019-6-3-8rpmj-424Research ArticleОбзорыReviewФИТОТЕРАПИЯ ПРИ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЯХ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫPHYTOTHERAPY FOR INFLAMMATORY DISEASES OF THE PROSTATEhttps://orcid.org/0000-0002-4468-3670КульченкоН. Г.KulchenkoN. G.

к.м. н., врач-уролог, врач ультразвуковой диагностики, старший преподаватель кафедры гистологии, цитологии и эмбриологии

MD, PhD, urologist, ultrasound medical specialist, senior lectures of the departments of histology, cytology and embryology

kle-kni@mail.ruhttps://orcid.org/0000-0002-7255-6679ЯценкоЕ. В.YatsenkoE. V.

к.м .н., врач-уролог, врач ультразвуковой диагностики, заместитель главного врача по медицинской части

MD, PhD, urologist, ultrasound medical specialist, deputy chief physician

Медицинский институт ФГАОУ ВО «Российский университет дружбы народов»РоссияMedical Institute of Peoples' Friendship University of Russia (RUDN University)Russian FederationМедицинский центр «МедиКос» ООО ПКФ «ДОММ»РоссияMedical Clinic “MediCos”Russian Federation201904092019638797Copyright © Кульченко Н.Г., Яценко Е.В., 20192019Кульченко Н.Г., Яценко Е.В.Kulchenko N.G., Yatsenko E.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.rpmj.ru/rpmj/article/view/424

В статье обсуждается эффективность фитотерапии при воспалительных заболеваниях предстательной железы. В данном обзоре литературы приведены клинические исследования успешного использования растительных компонентов в лечении и профилактике хронического простатита и купировании симптомов нижних мочевыводящих путей (СНМП). Биологические активные вещества корня крапивы, семян тыквы, пальмы сабаль и цинка весьма эффективны в терапии хронического простатита за счет противовоспалительного, антипролиферативного, антиандрогенного и антиоксидантного действий. Фитопрепараты, содержащие эти вещества, могут быть рекомендованы в качестве первой линии коррекции СНМП при хроническом простите категорий III и IV; в качестве общеукрепляющего средства для мужчин, ведущих малоподвижный образ жизни в возрасте старше 35 лет.

The article discusses the effectiveness of herbal medicine in inflammatory diseases of the prostate. This literature review presents clinical studies of the successful use of herbal ingredients in the treatment of chronic prostatitis and relief of lower urinary tract symptoms (LUTS). Biological active substances of Urtica dioica, Cucurbita moschata, Saw palmetto (Serenoa repens), and zinc are effective in the treatment of chronic prostatitis due to anti-inflammatory, antiproliferative, antiandrogenic and antioxidant action. Phytopreparations containing these substances can be recommended as the first line of correction of LUTS in chronic forgive categories III and IV; as a general tonic for men leading a sedentary lifestyle over the age of 35 years.

фитотерапияхронический бактериальный простатитэкстракт корней крапивыэкстракт пальмы сабальэкстракт семян тыквыцинкSerenoa repensSaw palmettoUrtica dioicaCucurbita moschataсимптомы нижних мочевыводящих путейphytotherapychronic bacterial prostatitisSaw palmettoSerenoa repensCucurbita moschataUrtica dioicazinclower urinary tract symptoms (LUTS)Исследование проведено при поддержке компании «Си Эс Си Лтд». Спонсоры исследования и третьи лица не принимали участие в обработке и анализе данных и написании настоящей статьи.The research was carried out with the support of the “CSC Ltd” company. The study sponsors and the third parties have not been involved in the processing and analysis of the data and the writing of this article.ReferencesPirola GM, Verdacchi T, Rosadi S, Annino F, De Angelis M. Chronic prostatitis: current treatment options. Res Rep Urol. 2019 Jun 4;11:165–174. DOI: 10.2147/RRU.S194679Pirola GM, Verdacchi T, Rosadi S, Annino F, De Angelis M. Chronic prostatitis: current treatment options. Res Rep Urol. 2019 Jun 4;11:165–174. DOI: 10.2147/RRU.S194679Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Kimes T, Calhoun EA. Prevalence of and risk factors for prostatitis: population based assessment using physician assigned diagnoses. J Urol. 2007 Oct;178 (4 Pt 1):1333–7. DOI: 10.1016/j.juro.2007.05.140Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Kimes T, Calhoun EA. Prevalence of and risk factors for prostatitis: population based assessment using physician assigned diagnoses. J Urol. 2007 Oct;178 (4 Pt 1):1333–7. DOI: 10.1016/j.juro.2007.05.140Nickel JC. Prostatitis. Canadian Urological Association Journal. 2011;5 (5):306–5. DOI: 10.5489/cuaj.11211Nickel JC. Prostatitis. Canadian Urological Association Journal. 2011;5 (5):306–5. DOI: 10.5489/cuaj.11211Pontari MA, Joyce GF, Wise M, McNaughton-Collins M. Urologic Diseases in America Project. Prostatitis. J Urol. 2007 Jun;177 (6):2050–7. DOI: 10.1016/j.juro.2007.01.128Pontari MA, Joyce GF, Wise M, McNaughton-Collins M. Urologic Diseases in America Project. Prostatitis. J Urol. 2007 Jun;177 (6):2050–7. DOI: 10.1016/j.juro.2007.01.128Аполихин О. И., Комарова В. А., Никушина А .А., Сивков А. В. Болезни предстательной железы в Российской Федерации: статистические данные 2008–2017 гг. Экспериментальная и клиническая урология. 2019;2:4–13. DOI: 10.29188/2222–8543–2019–11–2-4–12Apolihin OI, Komarova VA, Nikushina AA, Sivkov AV. Prostate diseases in the Russian Federation: statistical data for 2008– 2017. Experimental and Clinical Urology. 2019;2:4–13. DOI: 10.29188/2222–8543–2019–11–2-4–12 (In Russian)Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999 Jul 21;282 (3):236–7. DOI: 10.1001/jama.282.3.236Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999 Jul 21;282 (3):236–7. DOI: 10.1001/jama.282.3.236Виноградов И.В., Живулько А.Р., Короле в С.В. Хронический простатит, патогенетические механизмы влияния на мужскую фертильность. Вестник последипломного медицинского образования. 2018;4:48–54Vinogradov IV, Zhivulko AR, Korolev SV. Chronic prostatitis, pathogenetic mechanisms of influence on male fertility. Journal of Postgraduate Medical Education. 2018;4:48–54. (In Russian)Stamatiou K, Pierris N. Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study. Arch Ital Urol Androl. 2013 Dec 31;85 (4):190–6. DOI: 10.4081/aiua.2013.4.190Stamatiou K, Pierris N. Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study. Arch Ital Urol Androl. 2013 Dec 31;85 (4):190–6. DOI: 10.4081/aiua.2013.4.190Wagenlehner FM, van Till JW, Magri V, Perletti G, Houbiers JG, Weidner W, Nickel JC. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol. 2013 May;63 (5):953–9. DOI: 10.1016/j.eururo.2012.10.042Wagenlehner FM, van Till JW, Magri V, Perletti G, Houbiers JG, Weidner W, Nickel JC. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol. 2013 May;63 (5):953–9. DOI: 10.1016/j.eururo.2012.10.042Капр ин А.Д., Кос тин А.А., П опов С.В. Медикаментозная терапия хронического простатита. Русский медицинский журнал. Медицинское обозрение. 2015;23 (17):1010–2Kaprin AD, Kostin AA, Popov SV. Medikamentoznaya terapiya khronicheskogo prostatita. RMJ (Russian Medical Journal). 2015;23 (17):1010–2. (In Russian)Weidner W. Treating chronic prostatitis: antibiotics no, alpha-blockers maybe. Ann Intern Med. 2004 Oct 19;141 (8):639–40. DOI: 10.7326/0003–4819–141-8–200410190–00012Weidner W. Treating chronic prostatitis: antibiotics no, alpha-blockers maybe. Ann Intern Med. 2004 Oct 19;141 (8):639–40. DOI: 10.7326/0003–4819–141-8–200410190–00012Попов С.В. , Мазо Е.Б. Этиотропная терапия хронического бактериального простатита. Урология. 2008;3:36–41Popov SV, Mazo EВ. Etiotropic therapy of chronic bacterial prostatitis. Urology. 2008;3:36–41. (In Russian)Cunha BA, Gran A, Raza M. Persistent extended-spectrum β-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline. Int J Antimicrob Agents. 2015 Apr;45 (4):427–9. DOI: 10.1016/j. ijantimicag.2014.12.019Cunha BA, Gran A, Raza M. Persistent extended-spectrum β-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline. Int J Antimicrob Agents. 2015 Apr;45 (4):427–9. DOI: 10.1016/j. ijantimicag.2014.12.019Magri V, Boltri M, Cai T, Colombo R, Cuzzocrea S, De Visschere P, et al. Multidisciplinary approach to prostatitis. Arch Ital Urol Androl. 2019 Jan 18;90 (4):227–248. DOI: 10.4081/aiua.2018.4.227Magri V, Boltri M, Cai T, Colombo R, Cuzzocrea S, De Visschere P, et al. Multidisciplinary approach to prostatitis. Arch Ital Urol Androl. 2019 Jan 18;90 (4):227–248. DOI: 10.4081/aiua.2018.4.227Engelmann U, Walther C, Bondarenko B, Funk P, Schlafke S. Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin. Arzneimittelforschung. 2006;56 (3):222–9. DOI: 10.1055/s-0031–1296714Engelmann U, Walther C, Bondarenko B, Funk P, Schlafke S. Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin. Arzneimittelforschung. 2006;56 (3):222–9. DOI: 10.1055/s-0031–1296714Hu M, Wazir J, Ullah R, Wang W, Cui X, Tang M, Zhou X. Phytotherapy and physical therapy in the management of chronic prostatitis-chronic pelvic pain syndrome. Int Urol Nephrol. 2019 Jul;51 (7):1081–1088. doi: 10.1007/s11255–019–02161-xHu M, Wazir J, Ullah R, Wang W, Cui X, Tang M, Zhou X. Phytotherapy and physical therapy in the management of chronic prostatitis-chronic pelvic pain syndrome. Int Urol Nephrol. 2019 Jul;51 (7):1081–1088. doi: 10.1007/s11255–019–02161-xSaavedra MJ, Aires A, Dias C, Almeida JA, De Vasconcelos MC, Santos P, Rosa EA. Evaluation of the potential of squash pumpkin by-products (seeds and shell) as sources of antioxidant and bioactive compounds. J Food Sci Technol. 2015 Feb;52 (2):1008–15. DOI: 10.1007/s13197–013–1089–5Saavedra MJ, Aires A, Dias C, Almeida JA, De Vasconcelos MC, Santos P, Rosa EA. Evaluation of the potential of squash pumpkin by-products (seeds and shell) as sources of antioxidant and bioactive compounds. J Food Sci Technol. 2015 Feb;52 (2):1008–15. DOI: 10.1007/s13197–013–1089–5Safarinejad MR. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study. J Herb Pharmacother. 2005;5 (4):1–11Safarinejad MR. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study. J Herb Pharmacother. 2005;5 (4):1–11De Monte C, Carradori S, Granese A, Di Pierro GB, Leonardo C, De Nunzio C. Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms. BMC Urol. 2014 Aug 11;14:63. DOI: 10.1186/1471–2490–14–63De Monte C, Carradori S, Granese A, Di Pierro GB, Leonardo C, De Nunzio C. Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms. BMC Urol. 2014 Aug 11;14:63. DOI: 10.1186/1471–2490–14–63Damiano R, Cai T, Fornara P, Franzese CA, Leonardi R, Mirone V. The role of Cucurbita pepo in the management of patients affected by lower urinary tract symptoms due to benign prostatic hyperplasia: A narrative review. Arch Ital Urol Androl. 2016 Jul 4;88 (2):136–43. DOI: 10.4081/aiua.2016.2.136Damiano R, Cai T, Fornara P, Franzese CA, Leonardi R, Mirone V. The role of Cucurbita pepo in the management of patients affected by lower urinary tract symptoms due to benign prostatic hyperplasia: A narrative review. Arch Ital Urol Androl. 2016 Jul 4;88 (2):136–43. DOI: 10.4081/aiua.2016.2.136Chrubasik JE, Roufogalis BD, Wagner H. A comprehensive review on the stinging nettle effect and efficacy profiles Part II: Urtica radix. Phytomedicine. 2007 Aug;14 (7–8):568–79. DOI:10.1016/j.phymed.2007.03.014Chrubasik JE, Roufogalis BD, Wagner H. A comprehensive review on the stinging nettle effect and efficacy profiles Part II: Urtica radix. Phytomedicine. 2007 Aug;14 (7–8):568–79. DOI: 10.1016/j.phymed.2007.03.014Кульченко Н.Г. Оптимизация подходов консервативной терапии доброкачественной гиперплазии предстательной железы ингибиторами 5-альфаредуктазы. Клинико-морфологическое исследование. Курский научно-практический вестник «Человек и его здоровье». 2012;1:101–6Kulchenko NG. Optimizing the conservative therapy of benign prostatic hyperplasia by inhibitors of 5–alfareductase. Clinical and morphological study. Kursk scientific and practical bulletin «Man and his health». 2012;1:101–6. (In Russian)Yang J, Te AE. Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome. Curr Urol Rep. 2005 Jul;6 (4):290–5Yang J, Te AE. Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome. Curr Urol Rep. 2005 Jul;6 (4):290–5Gordon AE, Shaughnessy AF. Saw palmetto for prostate disorders. Am Fam Physician. 2003 Mar 15;67 (6):1281–3Gordon AE, Shaughnessy AF. Saw palmetto for prostate disorders. Am Fam Physician. 2003 Mar 15;67 (6):1281–3Colado-Velázquez J, Mailloux-Salinas P, Medina-Contreras JML, Cruz-Robles D, Bravo G. Effect of Serenoa repens on oxidative stress, inflammatory and growth factors in obese wistar rats with benign prostatic hyperplasia. Phytother Res. 2015 Oct;29 (10):1525–31. DOI: 10.1002/ptr.5406Colado-Velázquez J, Mailloux-Salinas P, Medina-Contreras JML, Cruz-Robles D, Bravo G. Effect of Serenoa repens on oxidative stress, inflammatory and growth factors in obese wistar rats with benign prostatic hyperplasia. Phytother Res. 2015 Oct;29 (10):1525–31. DOI: 10.1002/ptr.5406Penugonda K, Lindshield B. Fatty acid and phytosterol content of commercial saw palmetto supplements. Nutrients. 2013 Sep 13;5 (9):3617–33. DOI: 10.3390/nu5093617Penugonda K, Lindshield B. Fatty acid and phytosterol content of commercial saw palmetto supplements. Nutrients. 2013 Sep 13;5 (9):3617–33. DOI: 10.3390/nu5093617Procida G, Stancher B, Cateni F, Zacchigna M. Chemical composition and functional characterisation of commercial pumpkin seed oil. J Sci Food Agric. 2013 Mar 30;93 (5):1035–41. DOI: 10.1002/jsfa.5843Procida G, Stancher B, Cateni F, Zacchigna M. Chemical composition and functional characterisation of commercial pumpkin seed oil. J Sci Food Agric. 2013 Mar 30;93 (5):1035–41. DOI: 10.1002/jsfa.5843Tantawy SA, Elgohary HM, Kamel DM. Trans-perineal pumpkin seed oil phonophoresis as an adjunctive treatment for chronic nonbacterial prostatitis. Res Rep Urol. 2018 Sep 18;10:95–101. DOI: 10.2147/RRU.S167896Tantawy SA, Elgohary HM, Kamel DM. Trans-perineal pumpkin seed oil phonophoresis as an adjunctive treatment for chronic nonbacterial prostatitis. Res Rep Urol. 2018 Sep 18;10:95–101. DOI: 10.2147/RRU.S167896Hong H, Kim CS, Maeng S. Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutr Res Pract. 2009 Winter;3 (4):323–7. DOI: 10.4162/nrp.2009.3.4.323Hong H, Kim CS, Maeng S. Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutr Res Pract. 2009 Winter;3 (4):323–7. DOI: 10.4162/nrp.2009.3.4.323Guan Q, Zheng Y, Wei X, Wang S, Su B, Yu S. The Effect of Flavonoids on Chronic Prostatitis: A Meta-analysis of Published Randomized Controlled Trials. J Natl Med Assoc. 2019 May 23. pii: S0027–9684 (19)30011–2. DOI: 10.1016/j.jnma.2019.04.007Guan Q, Zheng Y, Wei X, Wang S, Su B, Yu S. The Effect of Flavonoids on Chronic Prostatitis: A Meta-analysis of Published Randomized Controlled Trials. J Natl Med Assoc. 2019 May 23. pii: S0027–9684 (19)30011–2. DOI: 10.1016/j.jnma.2019.04.007Schilcher H, Dunzendorfer U, Ascali F. D7-Sterols: the prostatotropic principle of pumpkin seeds. Urologe B. 1987;27:316–319Schilcher H, Dunzendorfer U, Ascali F. D7-Sterols: the prostatotropic principle of pumpkin seeds. Urologe B. 1987;27:316–319Abdel-Rahman MK. Effect of pumpkin seed (Cucurbita pepo L) diets on benign prostatic hyperplasia (BPH): chemical and morphometric evaluation in rats. World J Chem. 2006;1 (1):33–40Abdel-Rahman MK. Effect of pumpkin seed (Cucurbita pepo L) diets on benign prostatic hyperplasia (BPH): chemical and morphometric evaluation in rats. World J Chem. 2006;1 (1):33–40Moradi HR, Erfani Majd N, Esmaeilzadeh S, Fatemi Tabatabaei SR. The histological and histometrical effects of Urtica dioica extract on rat’s prostate hyperplasia. Vet Res Forum. 2015 Winter;6 (1):23–9Moradi HR, Erfani Majd N, Esmaeilzadeh S, Fatemi Tabatabaei SR. The histological and histometrical effects of Urtica dioica extract on rat’s prostate hyperplasia. Vet Res Forum. 2015 Winter;6 (1):23–9Pigat N, Reyes-Gomez E, Boutillon F, Palea S, Barry Delongchamps N, Koch E, Goffin V. Combined Sabal and Urtica Extracts (WS® 1541) Exert Anti-proliferative and Anti-inflammatory Effects in a Mouse Model of Benign Prostate Hyperplasia. Front Pharmacol. 2019 Mar 29;10:311. DOI: 10.3389/fphar.2019.00311Pigat N, Reyes-Gomez E, Boutillon F, Palea S, Barry Delongchamps N, Koch E, Goffin V. Combined Sabal and Urtica Extracts (WS® 1541) Exert Anti-proliferative and Anti-inflammatory Effects in a Mouse Model of Benign Prostate Hyperplasia. Front Pharmacol. 2019 Mar 29;10:311. DOI: 10.3389/fphar.2019.00311Dhouibi R, Affes H, Ben Salem M, Hammami S, Sahnoun Z, Zeghal KM, Ksouda K. Screening of pharmacological uses of Urtica dioica and others benefits. Prog Biophys Mol Biol. 2019 Jun 1. pii: S0079–6107 (19)30098–7. DOI: 10.1016/j.pbiomolbio.2019.05.008Dhouibi R, Affes H, Ben Salem M, Hammami S, Sahnoun Z, Zeghal KM, Ksouda K. Screening of pharmacological uses of Urtica dioica and others benefits. Prog Biophys Mol Biol. 2019 Jun 1. pii: S0079–6107 (19)30098–7. DOI: 10.1016/j.pbiomolbio.2019.05.008Cheetham PJ. Role of complimentary therapy for male LUTS. Curr Urol Rep. 2013 Dec;14 (6):606–13. DOI: 10.1007/s11934–013–0372–3Cheetham PJ. Role of complimentary therapy for male LUTS. Curr Urol Rep. 2013 Dec;14 (6):606–13. DOI: 10.1007/s11934–013–0372–3Powell SR. The antioxidant properties of zinc. J Nutr. 2000May;130(5S Suppl):1447S-54S. DOI: 10.1093/jn/130.5.1447SPowell SR. The antioxidant properties of zinc. J Nutr. 2000May;130(5S Suppl):1447S-54S. DOI: 10.1093/jn/130.5.1447SCostello LC, Franklin RB. A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Arch Biochem Biophys. 2016 Dec 1;611:100–112. DOI: 10.1016/j.abb.2016.04.014Costello LC, Franklin RB. A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Arch Biochem Biophys. 2016 Dec 1;611:100–112. DOI: 10.1016/j.abb.2016.04.014Flynn A, Hirvonen T, Mensink GB, Ocké MC, Serra-Majem L, Stos K, et al. Intake of selected nutrients from foods, from fortifi-cation and from supplements in various European countries. Food Nutr Res. 2009 Nov 12;53. DOI: 10.3402/fnr.v53i0.2038Flynn A, Hirvonen T, Mensink GB, Ocké MC, Serra-Majem L, Stos K, et al. Intake of selected nutrients from foods, from fortifi-cation and from supplements in various European countries. Food Nutr Res. 2009 Nov 12;53. DOI: 10.3402/fnr.v53i0.2038Cui D, Han G, Shang Y, Mu L, Long Q, Du Y. The effect of chronic prostatitis on zinc concentration of prostatic fluid and seminal plasma: a systematic review and meta-analysis. Curr Med Res Opin. 2015;31 (9):1763–9. DOI: 10.1185/03007995.2015.1072707Cui D, Han G, Shang Y, Mu L, Long Q, Du Y. The effect of chronic prostatitis on zinc concentration of prostatic fluid and seminal plasma: a systematic review and meta-analysis. Curr Med Res Opin. 2015;31 (9):1763–9. DOI: 10.1185/03007995.2015.1072707Goodarzi D, Cyrus A, Baghinia MR, Kazemifar AM, Shirincar M. The efficacy of zinc for treatment of chronic prostatitis. Acta Med Indones. 2013 Oct;45 (4):259–64Goodarzi D, Cyrus A, Baghinia MR, Kazemifar AM, Shirincar M. The efficacy of zinc for treatment of chronic prostatitis. Acta Med Indones. 2013 Oct;45 (4):259–64

The authors declare that there are no conflicts of interest present.